抗病毒组合疗法作为免疫受损宿主持续性COVID-19的救援疗法
Roberta Maria Antonello1, Davide Marangoni1, Filippo Ducci1
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Journal of chemotherapy (Florence, Italy)
|June 14, 2024
概括
组合抗病毒疗法在血液恶性瘤的免疫功能低下患者治疗持久的SARS-CoV-2感染方面表现有前途. 这种方法一般耐受良好,在大多数情况下都取得了临床和病毒学上的成功.
科学领域:
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
- 病毒学 病毒学
背景情况:
- 严重和长期的SARS-CoV-2感染在免疫功能低下的人群中构成重大挑战.
- 患有血液性恶性瘤的患者特别容易受到持续性病毒感染和治疗失败的影响.
研究的目的:
- 评估在免疫功能低下的患者中持续性SARS-CoV-2感染的组合抗病毒治疗的疗效和耐受性.
- 评估在接受新型抗病毒组合的血液恶性瘤患者的临床和病毒学结果.
主要方法:
- 分析了9名患有血液性恶性瘤和持久性SARS-CoV-2感染的患者的病例系列.
- 患者接受了10天的组合抗病毒疗法,包括尼尔马特雷尔维尔/里托纳维尔,莫尔努皮拉维尔和雷梅西维尔,有时与索特罗维马布.
- 为了评估,收集了临床,病毒学和放射学数据.
主要成果:
- 综合抗病毒疗法在患者队列中一般耐受良好.
- 在9名患者中,有8名患者取得了临床和病毒学上的成功,放射学随访证实了这一点.
- 一名患者实现了病毒清除,但因其潜在的血液恶性瘤而死亡.
结论:
- 组合抗病毒疗法代表了管理持续性COVID-19在免疫受损患者的潜在基石.
- 为了验证这些发现并优化治疗策略,对更大的队列进行进一步的前性研究至关重要.
关键词:
这就是SARS-CoV-2病毒.组合组合组合的组合组合.莫尔努皮拉维尔 (Molnupiravir) 是一种尼尔马特雷尔维尔 / 里托纳维尔在标签之外的标签这是一个复发性复发.雷梅西维尔 (remdesivir) 是一种药物.救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援救援这就是Sotrovimab.更多相关视频
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.2K
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.7K
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Immune Response Against Viral Pathogens
775
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
775
Acute Respiratory Failure-V
132
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
132
